Renaissance Capital logo

BTAI News

US IPO Weekly Recap: Another billion-dollar IPO filing as activity prepares to pick up

BTAI

The lull is over. The annual February pause in IPO activity lasted longer than normal, but 2018's record-breaking start now looks ready to resume. This week IPOs began launching and another billion-dollar IPO joined ...read more

BioXcel Therapeutics prices IPO at $11, the low end of the range

BioXcel Therapeutics logo

BioXcel Therapeutics, which is developing new uses of drugs to treat neurological disorders and cancer, raised $60 million by offering 5.5 million shares at $11, the low end of the range of $11 to $13. BioXcel Therapeutics plans to list on the Nasdaq under the...read more

US IPO Week Ahead: 1 biotech expected in the week ahead, 4 deals could launch starting Monday

BTAI

Only one small biotech is on the calendar for the week ahead as the annual mid-February lull has been drawn out slightly longer than expected. That said, four deals are able to launch on Monday and another three become eligible the week after, including...read more

AI-based drug discovery biotech BioXcel Therapeutics sets terms for $60 million IPO

BioXcel Therapeutics logo

BioXcel Therapeutics, which is utilizing AI to develop new uses of drugs to treat neurological disorders and cancer, announced terms for its IPO on Tuesday. The Branford, CT-based company plans to raise $60 million by offering 5.0 million shares at a price...read more